Современные подходы к комплексной терапии перинатальных поражений ЦНС у новорожденных


Н.Н. Володин, С.О. Рогаткин

Асфиксия в родах – частое и тяжелое осложнение, занимающее одно из первых мест в структуре перинатальной смертности среди доношенных детей. У выживших перинатальная асфиксия может в будущем стать причиной развития тяжелых неврологических нарушений, задержки психомоторного развития. В обзоре подробно рассматриваются современные подходы к антенатальной церебропротекции у новорожденных из “группы высокого риска по развитию гипоксически-ишемического поражения ЦНС” и ранней постнатальной церебропротекции у новорожденных, перенесших тяжелую асфиксию. Обсуждаются проблемы профилактики и терапии отека мозга, лечения судорог при гипокически-ишемической энцефалопатии, предотвращения пери- и интраваскулярных кровоизлияний у недоношенных детей. Приводится информация о перспективных методах терапии гипоксически-ишемических поражений головного мозга у новорожденных.

Литература





  1. Барашнев Ю.И. Перинатальная неврология. М., 2001. 638 с.
  2. Володин Н.Н., Рогаткин С.О., Медведев М.И. Актуальные проблемы перинатальной неврологии на современном этапе // Журнал неврологии и психиатрии. 2001. Т. 101. № 7. С. 4–9.
  3. Гурина О.И. Клинико-иммунохимическая оценка нарушений функций гемато-энцефалического барьера у недоношенных детей с перинатальными поражениями ЦНС // Автореф. дис. канд. мед. наук. М., 1996.
  4. Савельева Г.М., Сичинава Л.Г. и соавт. Пути снижения перинатальной заболеваемости и смертности. // Южно-российский медицинский журнал. 1999. № 2. С. 37–41.
  5. Хачатрян А.В. Фармакологические методы защиты мозга новорожденных, перенесших гипоксию // Дис канд. мед. наук. М., 1998.
  6. Aguilar L, et al. Psycometric analysis in children with mental retardation due to perinatal hypoxia treated with fibroblast growth factor (FGF) & showing improvement in mental development. J Intellect Disabil Res 1993;37:507–20.
  7. Babnik J. Effect of vitamin E administration in cerebral hemorrhage in preterm infants. Eur J Pediatr 1991;150:602.
  8. Beilharz EJ, Bassett NS, Sirimanne ES, Williams CE, Gluckman PD. Insulin-like growth factor II is induced during wound repair following hypoxic-ischemic injury in the developing rat brain. Brain Res Mol Brain Res 1995;29:81–91.
  9. Berger R, Lehmann T, Karcher J, et al. Low dose flunarizine protects the fetal brain from ischemic injury in sheep. Pediatr Res 1998;44:277–82.
  10. Chumas PD, Del Bigio MR, Drake JM, et al. A comparison of the protective effect of dexamethasone to other potential prophylactic agents in a neonatal rat model of cerebral hypoxic-ischemia. J Neurosurg 1993;79:414–20.
  11. Clancy RR, McGaurn SA, Coin JE, et al. Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics 2001;108:61–70.
  12. Cornette L, Levene MI. Post-resuscitative management of the asphyxiated term and preterm infant. Semin Neonatol 2001;6:271–82.
  13. Evans DJ, Levene MI. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Library 2001.
  14. Galvin KA, Oorschot DE. Postinjury magnesium sulfate treatment is not markedly neuroprotective for striatal medium spiny neurons after perinatal hypoxia/ischemia in the rat. Pediatr Res 1998;44:740–45.
  15. Garland J, et al. Effect of maternal glucocorticoid exposure on risk of severe intraventricular hemorrhage in surfactant treated preterm infants. J Pediatr 1995;126:272–79.
  16. Giacoia G. Asphyxial brain damage in the newborn: new insights into the pathology & possible pharmacologic interventions. South Med J 1993;86:676–82.
  17. Gilstrap L, et al. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413–8.
  18. Gluckman PD, Pinal CS, Gunn AJ. Hypoxic-ischemic brain injury in the newborn: pathophysiology and potential strategies for intervention. Semin Neonatol 2001;6:109–20.
  19. Gray P. Perinatal hypoxic-ischemic brain injury:prediction of outcome. Devel Med Child Neurol 1993;35:965–73.
  20. Hagberg H, et al. Hypoxia-ischemia in the neonatal rat brain: histopathology after posttretment with NMDA receptor antagonists. Biol Neonate 1994;66:205–13.
  21. Hall RT, Hall FK, Daily DK. High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up. J Pediatr 1998;132:345–48.
  22. Hattori H. Involvement of excitatory amino acids in the brain damage of neonatal asphyxia. No To Hattatsu 1994;26:125–29.
  23. Hoffman D. Protective effect of magnesium on brain cell membrane function. during cerebral hypoxia in newborn piglets. Pediatr Res 1993;33:215A.
  24. Hoffman D, Marro PJ, McGowan JE, et al. Protective effect of MgS04 infusion on NMDA receptor biding characteristics during cerebral cortical hypoxia in the newborn piglet. Brain Res 1994;644:144–49.
  25. Imai T, et al. Effect of calcium antagonist, nicardipine, on cerebral blood flow in postasphyxial newborn piglets. Acta Pediatr Jpn 1995;37:297–01.
  26. Klink F. The effect of piracetam on the foetus sub partu. 2-nd international symposium on nootropic drugs. Mexico 1981,269–75.
  27. Kubo T, et al. Brain-derived neurotrophic factor (BDNF) can prevent apoptosis of rat cerebellar granule neurons in culture. Devel Brain Res 1995, 85.
  28. Law J. Cerebral perfusion, metabolism and outcome. Curr Opin Pediatr 1995;7:132–39.
  29. Levene M, Blennow M, Whitelaw A, et al. Acute effects of two different does of magnesium sulphate in infants with birth asphyxia. Arch Dis Child 1995;73:174–77.
  30. Levene M. Role of excitatory amino acid antagonists in the management of birth asphyxia. Biol Neonate 1992;62:248–51.
  31. Low J, et al. The role of systemic blood pressure in the regulation of cerebral blood velocity in the newborn. Pediatr Res 1993;33:223A.
  32. Low M, et al. Is routine vitamin E administration justified in very low birth-weight infants? Devel Med Child Neurol 1990;32:442–50.
  33. Marret S, Gressens P, Gadisseux JF, et al. Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies. Dev Med Child Neurol 1995;37:473–84.
  34. Marret S, et al. Prevention by magnesium of excitotoxic neuronal death in the developing brain: in animal model for clinical intervention studies. Devel Med Child neurol 1995,37.
  35. Marro P J, et al. Effect of xanthine oxidase inhibitor on brain cell membrane function in hypoxic newborn piglets. Pediatr Res 1991;29:225A.
  36. Marro PJ, Hoffman D, Schneiderman R, et al. Effect of allopurinol on NMDA receptor modification following recurrent asphyxia in newborn piglets. Brain Res 1998;787:71–7.
  37. Ment L, et al. Antenatal steroids, delivery mode, & intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol 1995;172:795–800.
  38. Miller V. Pharmacologic management of neonatal cerebral ischemia and hemmorhage: old and new directions. J Child Neurol 1993;8:7–18.
  39. Nelson K, et al. Can magnesium sulfate reduce the risk of cerebral palsy in VLBW infants? Pediatrics 1995;95:263–69.
  40. Palmer C, Roberts R. Reduction of perinatal brain damage with oxypurinol treatment after hypoxic – ischemic injury. Pediatr Res 1991;29:362A.
  41. Palmer CR. Vannucci. Potential new therapies for perinatal cerebral hypoxia-ischemia. Clin Perinatol 1993;20:411–32.
  42. Park CK, Nehls DG, Graham DI, et al. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol 1998;24:543–51.
  43. Peeters C, van Bel F. Pharmacotherapeutical reduction of post-hypoxic-ischemic brain injury in the newborn. Biol Neonate 2001;79:274–80.
  44. Poland R. Vitamin E for prevention of perinatal intracranial hemorrhage. Pediatrics 1990;85:578–84.
  45. Pourcyrous M, et al. Brain superoxide anion generation in asphyxiated piglets & the effect of indomethacin at therapeutic dose. Pediatr Res 1993;34:366–69.
  46. Powers W. Acute hypertension after stroke: the scientific basis for treatment decisions. Neurol 1993;43:461–7.
  47. Qureshi AI, Suarez JI. Use of hypertonic sale solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med 2000;28:3301–13.
  48. Ramaerkers V, et al. Defective regulation of cerebral oxygen transport after severe burth asphyxia. Dev Med Child Neurol 1990;85:39–41.
  49. Ramji S, Ahuja S, Thirupuram S, et al. Resuscitation of asphyxic newborn infants with room air revents oxidative stress in moderately asphyxiated term neonates. Pediatrics 2001;107:642–47.
  50. Regan RF, Jasper E, Quo YP, et al. The effect of magnesium on oxidative neuronal injury in vivo effects. J Neurochem 1998;70:77–85.
  51. Sacco RL, DeRosa JT, Haley EC, et al. Glycine antagonist in neuroprotection for patients with acute stroke. GAIN Americas: a randomized controlled trial. JAMA 2001;285:1719–61.
  52. Shah P. Newborn health around the Globe. International child health: a digest of current information 1994;5:63–8.
  53. Tholl D, et al. Meta-analysis of phenobarbital usage for prevention of intraventricular hemorrhage in premature infants: factors related to variation in outcome. Clin Trials Meta-analys 1994;29:177–90.
  54. Toth-Heyn P, Drukker A, Guignard JP. The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol 2000;14:227–39.
  55. Tuor UI, Chumas PD, De Bigio MR. Prevention of hypoxic/ischemic damage with dexamethasone is dependent on age and not influenced by fasting. Exper Neurol 1995;132:116–22.
  56. Valfai J. Effect of vitamin E on periventricular/intraventricular hemorrhage & posthemorrhagic hydrocephalus. Pediatr Res 1993;333:2440A.
  57. Van Bel F, Shadid M, Moison RMW, et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 1998;101:185–93.
  58. Vannucci R. Cerebral carbohydrate and energy metabolism in perinatal hypoxic-ischemic brain damage. Brain Pathol 1992;2(3):229–34.
  59. Vannucci RJ. Yager. Glucose, lactic acid and perinatal hypoxic-ischemic brain damage. Pediatr Neurol 1992;8):3–12.
  60. Vento M, Asensi M, Sastre J, et al. Resuscitation with room air instead of 100 % oxygen prevents oxidative stress in moderately asphyxiated term neonates. Pediatrics 2001;107:642–7.
  61. Vento M, Asensi M, Sastre J, et al. Six years of experience with the use of room air for the resuscitation of asphyxiated newly born term infants. Biol Neonate 2001;79:261–67.
  62. Voll C, Auer R. Postishemic seizures & necrotising ischemic brain damage: neuroprotective effect of postishemic diazepam & insulin. Neurol 1991;41:423–28.
  63. Volpe JJ. Perinatal brain injury: from pathogenesis to neuroprotection. MRDD Research Reviews 2001;7:56–64.
  64. Wells J, Ment L. Prevention of intraventricular hemorrhage in preterm infants. Early Hum Dev 1995;42:209–33.
  65. White B, et al. Brain injury by global ischemia & reperfusion: a theoretical perspective on membrane damage & repair. Neurol 1993;43:1656–65.
  66. Williams GD, Palmer C, Heitjan DF, et al. Allopurinol preserves cerebral energy metabolism during perinatal hypoxia-ischemia: a 31P NMR study in unanesthetized immature rats. Neurosci Lett 1992;144:103–06.
  67. Woodgate PG, Davies MW. Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated newborn infants. Cochrane Library Disk Issue 2001.
  68. Wyckoff MH, Perlman J, Niermeyer S. Medications during resuscitation – what is the evidence? Semin Neonatol 2001;6:251–59.
  69. Yip, et al. Effect of plasma glucose on infarct size in focal cerebralischemia-reperfusion. Neurol 1991;41:899–905.
  70. Uematsu D, et al. Combined therapy with MK-801 & nimodipine for protection of ischemic brain damage. Neurol 1991;41:88–94.
  71. Moise A, et al. Treatment of hypotension in a 24 week premature infant: a national survey. Pediatr Res 1993;33:223A.



Бионика Медиа